Cytotoxic Epstein-Barr virus-positive large B cell lymphoma: A regulatory B cell-derived neoplasia?

Valentina Tabanelli, Vanessa Santiago-Pacheco, Mario Corbellino, Angelica Calleri, Claudio Agostinelli, Carlo Parravicini, Stefano A. Pileri

Research output: Contribution to journalArticle

Abstract

Aims: A new subtype of granzyme B (GrB)-producing regulatory B cells (Bregs) has been described recently; these peculiar cytotoxic B cells are increased significantly in interleukin (IL)-21-rich settings, and in particular during HIV and Epstein-Barr virus (EBV) infection. Our aim is to report a unique case of an EBV-positive diffuse large B cell lymphoma (DLBCL) with cytotoxic features arisen in an HIV+ patient, and to understand if this lesion may represent a proliferation of neoplastic cytotoxic Bregs. Methods and results: We describe a 66-year-old male patient who presented with cervical lymph node enlargement and B symptoms; subsequently, HIV infection was diagnosed. Histopathological, immunohistochemical and molecular studies were performed, and revealed an EBV-positive DLBCL with cytotoxic features. Considering the immunological setting and unconventional phenotype observed, we tried to evaluate further the expression of GrB and IL-21 in another 150 aggressive B cell lymphomas (17 of 150 EBV+, two of 150 EBV+/HIV+). Minimal dot-like expression of GrB was found in seven lymphomas (in fewer than 1% of tumour cells), three of which were EBV-positive. Conclusions: Breg origin has never been reported in B cell lymphomas. We describe an exceptional case of EBV-positive DLBCL with aberrant expression of cytotoxic markers in a patient with a previously unknown HIV infection. We propose cytotoxic Bregs as a possible normal counterpart for this unusual tumour.

Original languageEnglish
JournalHistopathology
DOIs
Publication statusPublished - 2017

Fingerprint

Regulatory B-Lymphocytes
B-Cell Lymphoma
Human Herpesvirus 4
Granzymes
Lymphoma, Large B-Cell, Diffuse
Neoplasms
HIV
HIV Infections
Epstein-Barr Virus Infections
Lymphoma
B-Lymphocytes
Lymph Nodes
Phenotype

Keywords

  • DLBCL
  • EBV
  • HIV
  • B
  • Cytotoxic
  • Granzyme B

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Histology

Cite this

Cytotoxic Epstein-Barr virus-positive large B cell lymphoma : A regulatory B cell-derived neoplasia? / Tabanelli, Valentina; Santiago-Pacheco, Vanessa; Corbellino, Mario; Calleri, Angelica; Agostinelli, Claudio; Parravicini, Carlo; Pileri, Stefano A.

In: Histopathology, 2017.

Research output: Contribution to journalArticle

@article{1e53b35cec5a4e91ab4fcd2e949a6cf9,
title = "Cytotoxic Epstein-Barr virus-positive large B cell lymphoma: A regulatory B cell-derived neoplasia?",
abstract = "Aims: A new subtype of granzyme B (GrB)-producing regulatory B cells (Bregs) has been described recently; these peculiar cytotoxic B cells are increased significantly in interleukin (IL)-21-rich settings, and in particular during HIV and Epstein-Barr virus (EBV) infection. Our aim is to report a unique case of an EBV-positive diffuse large B cell lymphoma (DLBCL) with cytotoxic features arisen in an HIV+ patient, and to understand if this lesion may represent a proliferation of neoplastic cytotoxic Bregs. Methods and results: We describe a 66-year-old male patient who presented with cervical lymph node enlargement and B symptoms; subsequently, HIV infection was diagnosed. Histopathological, immunohistochemical and molecular studies were performed, and revealed an EBV-positive DLBCL with cytotoxic features. Considering the immunological setting and unconventional phenotype observed, we tried to evaluate further the expression of GrB and IL-21 in another 150 aggressive B cell lymphomas (17 of 150 EBV+, two of 150 EBV+/HIV+). Minimal dot-like expression of GrB was found in seven lymphomas (in fewer than 1{\%} of tumour cells), three of which were EBV-positive. Conclusions: Breg origin has never been reported in B cell lymphomas. We describe an exceptional case of EBV-positive DLBCL with aberrant expression of cytotoxic markers in a patient with a previously unknown HIV infection. We propose cytotoxic Bregs as a possible normal counterpart for this unusual tumour.",
keywords = "DLBCL, EBV, HIV, B, Cytotoxic, Granzyme B",
author = "Valentina Tabanelli and Vanessa Santiago-Pacheco and Mario Corbellino and Angelica Calleri and Claudio Agostinelli and Carlo Parravicini and Pileri, {Stefano A.}",
year = "2017",
doi = "10.1111/his.13109",
language = "English",
journal = "Histopathology",
issn = "0309-0167",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Cytotoxic Epstein-Barr virus-positive large B cell lymphoma

T2 - A regulatory B cell-derived neoplasia?

AU - Tabanelli, Valentina

AU - Santiago-Pacheco, Vanessa

AU - Corbellino, Mario

AU - Calleri, Angelica

AU - Agostinelli, Claudio

AU - Parravicini, Carlo

AU - Pileri, Stefano A.

PY - 2017

Y1 - 2017

N2 - Aims: A new subtype of granzyme B (GrB)-producing regulatory B cells (Bregs) has been described recently; these peculiar cytotoxic B cells are increased significantly in interleukin (IL)-21-rich settings, and in particular during HIV and Epstein-Barr virus (EBV) infection. Our aim is to report a unique case of an EBV-positive diffuse large B cell lymphoma (DLBCL) with cytotoxic features arisen in an HIV+ patient, and to understand if this lesion may represent a proliferation of neoplastic cytotoxic Bregs. Methods and results: We describe a 66-year-old male patient who presented with cervical lymph node enlargement and B symptoms; subsequently, HIV infection was diagnosed. Histopathological, immunohistochemical and molecular studies were performed, and revealed an EBV-positive DLBCL with cytotoxic features. Considering the immunological setting and unconventional phenotype observed, we tried to evaluate further the expression of GrB and IL-21 in another 150 aggressive B cell lymphomas (17 of 150 EBV+, two of 150 EBV+/HIV+). Minimal dot-like expression of GrB was found in seven lymphomas (in fewer than 1% of tumour cells), three of which were EBV-positive. Conclusions: Breg origin has never been reported in B cell lymphomas. We describe an exceptional case of EBV-positive DLBCL with aberrant expression of cytotoxic markers in a patient with a previously unknown HIV infection. We propose cytotoxic Bregs as a possible normal counterpart for this unusual tumour.

AB - Aims: A new subtype of granzyme B (GrB)-producing regulatory B cells (Bregs) has been described recently; these peculiar cytotoxic B cells are increased significantly in interleukin (IL)-21-rich settings, and in particular during HIV and Epstein-Barr virus (EBV) infection. Our aim is to report a unique case of an EBV-positive diffuse large B cell lymphoma (DLBCL) with cytotoxic features arisen in an HIV+ patient, and to understand if this lesion may represent a proliferation of neoplastic cytotoxic Bregs. Methods and results: We describe a 66-year-old male patient who presented with cervical lymph node enlargement and B symptoms; subsequently, HIV infection was diagnosed. Histopathological, immunohistochemical and molecular studies were performed, and revealed an EBV-positive DLBCL with cytotoxic features. Considering the immunological setting and unconventional phenotype observed, we tried to evaluate further the expression of GrB and IL-21 in another 150 aggressive B cell lymphomas (17 of 150 EBV+, two of 150 EBV+/HIV+). Minimal dot-like expression of GrB was found in seven lymphomas (in fewer than 1% of tumour cells), three of which were EBV-positive. Conclusions: Breg origin has never been reported in B cell lymphomas. We describe an exceptional case of EBV-positive DLBCL with aberrant expression of cytotoxic markers in a patient with a previously unknown HIV infection. We propose cytotoxic Bregs as a possible normal counterpart for this unusual tumour.

KW - DLBCL

KW - EBV

KW - HIV

KW - B

KW - Cytotoxic

KW - Granzyme B

UR - http://www.scopus.com/inward/record.url?scp=85007336141&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85007336141&partnerID=8YFLogxK

U2 - 10.1111/his.13109

DO - 10.1111/his.13109

M3 - Article

AN - SCOPUS:85007336141

JO - Histopathology

JF - Histopathology

SN - 0309-0167

ER -